Author | Morgan Petronelli


Weekly Roundup: July 6-10

July 10, 2020

ICYMI, some of the stories featured this week include a look at the impact of apremilast treatment for psoriasis on a patient who also tested positive for COVID-19, exploring IL-17 inhibition for rosacea, FDA approvals for a cellulite injectable and atopic dermatitis treatment, plus more.

FDA accepts BLA for tralokinumab for atopic dermatitis

July 09, 2020

The U.S. Food and Drug administration has accepted the Biologics License Application for tralokinumab (LEO Pharma) for moderate-to-severe atopic dermatitis and is expected to make a decision in the second quarter of 2021.

The Cutaneous Connection: Episode 2- Sunscreen Controversies

July 09, 2020

With summer in full swing, this episode takes a look at how social media can influence sun protection use in teens and young adults, and why certain ingredients in sunscreens are considered controversial.

First injectable for cellulite approved by FDA

July 08, 2020

The U.S. FDA has approved collagenase clostridium histolyticum-aaes (Qwo, Endo International), making it the first FDA-approved injectable treatment for moderate-to-severe cellulite in the buttocks in adult women.